Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-03-13 Purchase | 2023-03-14 08:30 am | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 10,000 | $1.9593 | $19,593 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-08 Option Award | 2024-10-09 4:22 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Degnan Chris Chief Financial Officer | 87,592 | $0 | 87,592 (Direct) | View |
2023-02-25 Option Award | 2023-02-28 6:57 pm | N/A 2033-02-24 | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 185,000 | $0 | 185,000 (Direct) | View |
2022-02-28 Option Award | 2022-03-02 4:05 pm | N/A 2032-02-27 | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
2021-01-26 Option Award | 2021-01-28 4:05 pm | N/A 2031-01-25 | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 82,500 | $0 | 82,500 (Direct) | View |
2020-01-31 Option Award | 2020-02-04 6:02 pm | N/A 2030-01-30 | Galera Therapeutics Inc. | GRTX | Degnan Chris Chief Financial Officer | 74,435 | $0 | 74,435 (Direct) | View |